Scotts Miracle Gro Company (SMG)

Scotts Miracle-Gro Shares Rise 3% on Earnings Beat and Margin ExpansionApril 29, 2026 8:49 AM
IH Market News
The Scotts Miracle-Gro Company (NYSE:SMG) reported second-quarter results on Wednesday that came in ahead of analyst expectations, supported by revenue growth and improved margins.Shares gained 3.18% in premarket trading following the announcement.The company posted adjusted earnings per share of $4.53 for the quarter ended March 28, beating the consensus estimate of $3.86 by $0.67.Revenue totaled $1.46 billion, exceeding forecasts of $1.41 billion and rising 5% compared with the same period last year.The revenue increase was accompanied by a notable improvement in profitability, with adjusted gross margin expanding by 240 basis points to 41.8%.“We delivered a strong second quarter, executing on net sales growth, gross margin expansion and other key financial priorities,” said Mark Scheiwer. “We are driving profitability growth and improved free cash flow while making incremental investments in consumer activation and return-generating capital expenditures.”Scotts Miracle-Gro reaffirmed its full-year fiscal 2026 guidance, expecting adjusted earnings per share from continuing operations in the range of $4.15 to $4.35. The midpoint of $4.25 was not directly compared with a specific analyst consensus.The company also expects U.S. Consumer segment net sales to grow in the low single digits and forecasts an adjusted gross margin of at least 32%.Adjusted EBITDA increased 9% year over year to $437.4 million. The company’s net leverage ratio improved to 3.71x from 4.41x a year earlier, reflecting progress in reducing debt.Scotts Miracle-Gro expects to generate approximately $275 million in free cash flow for fiscal 2026, which it anticipates will help lower its leverage ratio into the high-3x range.ScottsMiracle-Gro stock price

Original: Scotts Miracle-Gro Shares Rise 3% on Earnings Beat and Margin Expansion

NYSE Content Update: Brazilian Fintech AGI to Open for TradeFebruary 11, 2026 8:56 AM
PR Newswire (US)

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 
Ashley Mastronardi delivers the pre-market update on February 11thMarkets are higher this morning as the DOW is coming off a third straight session closing above 50,000 and traders await the delayed January Jobs Report.Brazilian Fintech AGI (NYSE: AGBK) is celebrating its IPO this morning after raising $240 million.Scotts Miracle-Gro (NYSE: SMG) will celebrate its 30th anniversary by ringing the closing bell, with CFO Mark Scheiwer joining NYSE Live and Chief Gardening Officer Martha Stewart on-site as well.Opening Bell
Brazilian Fintech AGI (NYSE: AGBK) celebrates its IPOClosing Bell
Scotts Miracle-Gro (NYSE: SMG) marks 30 years on the NYSEFor market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com Video - https://mma.prnewswire.com/media/2902073/NYSE_Feb_11_Market_Update.mp4 
Photo - https://mma.prnewswire.com/media/2902072/Boyd_Photo_2_11.jpg 
Logo - https://mma.prnewswire.com/media/2581322/5793879/New_York_Stock_Exchange_Logo.jpg 



View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-update-brazilian-fintech-agi-to-open-for-trade-302685184.html

Original: NYSE Content Update: Brazilian Fintech AGI to Open for Trade

SMG anew 52=week high

SMG anew 52=week high

SMG new 52 week high

https://markets.businessinsider.com/news/stocks/alert-to-longterm-investors-of-the-scotts-miraclegro-company-smg-grabar-law-office-is-investigating-claims-on-your-behalf-1033562551

WHAT YOU CAN DO NOW: Current Scotts shareholders who have held Scotts shares since on or before November 1, 2021, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/Scotts-Shareholder-Investigation/, contact Joshua Grabar at jgrabar @FH-6085.

Attorney Advertising Disclaimer

SMG $57.86 -13.58 (-19.01%)

It's pot growing equipment biz slumped. Possibly growers too high to work?

https://stockcharts.com/h-sc/ui?s=smg

Scotts Miracle Gro Q3 EPS $1.17 Misses $1.41 Estimate, Sales $1.12B Miss $1.16B Estimate
BENZINGA
7:03 AM ET Aug-02-2023

Scotts Miracle Gro (NYSE:SMG) reported quarterly earnings of $1.17 per share which missed the analyst consensus estimate of $1.41 by 17.02 percent. This is a 40.91 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $1.12 billion which missed the analyst consensus estimate of $1.16 billion by 3.53 percent. This is a 5.66 percent decrease over sales of $1.19 billion the same period last year.

Is not a buy yet?? Doubled from low 40’s, but profit taking today it seems?

Nope not the time to buy as long as SMG has Hawthorne pulling it down.

It’s funny to me, wondering how many people on this board reading this post actually believe in any way that the reason Hawthorne is doing poorly has anything to do with the cannabis market in the US as far as overproduction. I mean, that excuse doesn’t even make sense which should show you how disconnected these people are from Cannabis.

Hawthornes slow motion but colossal failure is straight up the result of Hawthorne going to grow bro idiots who have been operating in their garage and assuming that they knew what products and equipment would be needed to scale. Spoiler alert, they had no idea what was required to scale.

I work in California cannabis at agricultural scale indoor, outdoor, greenhouse and have been involved with around 40% of the states licensed cannabis canopy. I can tell you with 100% certainty that l absolutely none of the brands/products/equipment that you find in a grow/hydro store that were purchased by Hawthorne like Cann Fan, Botanicare nutrients, etc. are used at any significant scale other than for the home grower and that’s it.

It has never ceased to amaze me that a blue chip company like SMG would eff up this bad as far as just simply not even doing any due diligence as to what the market really looked like down the road and what products or product type/formats would be appropriate for that.

Even before Scott’s bought all of these companies people had already begun to scale above and beyond the type of equipment offered by the companies Hawthorne acquired.

$SMG $76!!!! Huge mega boss buy time

Scott's Miracle Grow Weed Stock SMG

#SMG $SMG

YouTube Link:

Maybe should buy it now

Time to buy $SMG $121? Easy hold

Wells Fargo initiates coverage of Scotts Miracle-Gro. $180 price target

https://www.marketwatch.com/story/wells-fargo-launches-coverage-of-four-cannabis-stocks-11638887078?siteid=yhoof2

SCAM

$SMG These 5 Cannabis Stocks Have More Than Doubled Their Prices In The Last Year—And You Can Meet Their Management
https://www.benzinga.com/markets/cannabis/21/10/23305246/these-5-cannabis-stocks-have-more-than-doubled-their-prices-in-the-last-year-and-you-can-meet-th

Good to see this morning north again, great news they are buying back another 300M worth of stock this year. SCOTTS LONG

SMG was nice and green today :)

I've been adding too, company is in the best shape its ever been in. US Consumer doing good, Hawthorne growing 40-45%, recent acquisitions, share buy-back. Long term winner here.

time to catch a falling knife $144 :)

Scotts is making great moves, Hawthorne is growing fast.

I'm continuing to buy this dip, long runway when this starts moving north again.

$250 Million share buyback at these low prices is great news for long term shareholders.

Scotts takes 42% Stake in RIV Capital for $150 Million.

https://www.newcannabisventures.com/scotts-miracle-gro-cannabis-investment-vehicle-takes-42-stake-in-riv-capital-for-150-million/

Scotts purchased a warrant to buy equity in Dewey Scientific for $3.2 million

http://scottsmiraclegro.gcs-web.com/news-releases/news-release-details/scottsmiracle-gro-acquires-rhizoflora-assets-further-bolster

Scotts acquires HydroLogic Purification Systems

https://www.bizjournals.com/columbus/news/2021/08/05/miracle-grow-acquires-company.html

Scotts Acquires Rhizoflora

https://www.globenewswire.com/news-release/2021/08/16/2281531/33079/en/ScottsMiracle-Gro-Acquires-Rhizoflora-Assets-to-Further-Bolster-Hawthorne-Gardening-Portfolio-Announces-Investment-by-The-Hawthorne-Collective.html

this stay at home trade ran its course, now we look for the bottom



should find good support at $140-$150, then tons of support at $120-$130

so I guess I will buy this next week too $160s is a lot cheaper than $220



MAJOR TOP at $250

Another great quarter, company is growing like weeds :)

Investor day, use the link below.

https://kvgo.com/openexc/scottsmiraclegroinvestorandanalystday2021

$239.53, Scotts is KILLING IT, Great recent quarter. Hawthorne division led the company to its FIRST EVER profitable 1st quarter. Great job SCOTTS!

$220 going much much higher

SMG is growing because they own a bunch of hydroponic companies including General Hydroponics (nutrients), Gavita (commercial lighting), environmental controls and more under their subsidiary Hawthorne. https://www.hawthornegc.com/page/signature-brands No cannabis grower uses SMG oil. They either use coco coir, complete hydro, or organic live soil, sometimes fox farm soils.

As more Grow facilities are built SMG will have a significant revenue stream.

Gavita grow lights are a staple in many commercial grows and can be seen on YouTube shows cannacribs and growing exposed.

Is smg the only dirt company MJ is using to grow their products? Any cheaper stocks fertilizer companies out there?

Another great day, Scotts just keeps going up. Interesting news yesterday too, should help keep their products the best on the market.

Flowr and Hawthorne Canada Jointly Announce the Completion of the World's First Cannabis Research and Development Facility of its Kind
8:00 am ET January 5, 2021 (Globe Newswire) Print
North America's first research and development facility dedicated to advancing cannabis cultivation techniques and systems has been completed by The Flowr Corporation (TSXV: FLWR) and Hawthorne Canada Limited ("Hawthorne"). Hawthorne is a subsidiary of the Hawthorne Gardening Company division of The Scotts Miracle-Gro Company (NYSE:SMG). Scotts Miracle-Gro is the world's leading marketer of branded consumer lawn and garden products and indoor growing solutions. Flowr cultivates and sells premium cannabis to medical and adult-use markets in Canada, Europe and Australia.

Located on Flowr's cultivation campus in Kelowna, British Columbia, Canada, the R&D Center includes state-of-the-art laboratories, indoor grow suites, and training areas in a single building. Flowr will test cultivation systems and techniques using Hawthorne's advanced lighting, fertilization and irrigation systems, growing mediums, and research protocols. In addition, Flowr intends to focus its own research on cannabis genetics and integrated growing systems in line with its goal of delivering premium quality cannabis products through highly efficient cultivation.

"We built Hawthorne to help cultivators of all sizes grow quality plants with high levels of efficiency and consistency. Completing the industry's only dedicated R&D facility gives us a distinct advantage. We will leverage Flowr's cultivation expertise and our technical capabilities into real world testing and results that will make a difference to growers," said Chris Hagedorn, SVP & General Manager of Hawthorne Gardening. "We are proud of this collaboration with Flowr, a leading international cannabis company, with extensive growing experience indoors, in greenhouses and at-scale outdoors. Flowr is also one of a few companies that have had experience growing diverse genetics in different countries. We believe this experience will benefit our companies and the growers we serve."

"The completion of the R&D Center brings our work with Hawthorne fully to life and will help keep both companies on the leading edge of cannabis cultivation for years to come," commented Lance Emanuel, President and Interim Chief Executive Officer of Flowr. "Operationalizing the R&D Center is a major accomplishment for our organization and strengthens our competitive advantage in cultivation. We believe the long-term success of Flowr will be rooted in our ability to maximize the cannabinoid and terpene expression of genetics without sacrificing yield. The work we will do at the R&D Center will help us build upon the success we've had producing high quality, premium cannabis like our award-winning, flagship-strain BC Pink Kush beloved by budtenders and consumers throughout Canada. Leveraging our work at the R&D Center will be imperative to our eventual entry into the United States once federally permissible by law."

The R&D Center is the centerpiece of a strategic R&D partnership formed by Flowr and Hawthorne in March 2018. It brings two of the world's leading experts together to be at the forefront of cannabis cultivation. The operations will be led by Dr. Deron Caplan, the first person in North America to earn a PhD focused on cannabis cultivation and production. Dr. Caplan was awarded his doctorate by the University of Guelph in August 2018 and is Flowr's Director of Research and Development. The R&D Center will be staffed by Flowr's scientists, five of whom have PhDs in various plant biology, plant genetics and plant biochemistry disciplines. Hawthorne R&D will lead the research design and methodology.

All requisite licensing from Health Canada has been obtained by Flowr and the expectation is that the R&D Center will be operating at full capacity in Spring 2021. Research has already begun conducting growing trials at scale using Hawthorne products.

https://www.globenewswire.com/NewsRoom/AttachmentNg/ed973b58-e705-4797-9c77-71ca226d3cf8

Pictured: The Hawthorne R&D Center, from Flowr's Kelowna Campus in British Columbia.

About Hawthorne Gardening Company

Great day here.

This stock is a money machine! Up $86 per share this year.. And with $7.48 in dividends. SMG LONG!

Another fantastic quarter, LONG SMG!

More good news,

The company increased its guidance again this year, SCOTTS IS KILLING IT!

The Scotts Miracle-Gro Company SMG has provided an update for its fiscal 2020 view. The company expects net sales and adjusted earnings per share (EPS) to surpass its prior guidance issued in July.

For fiscal 2020 (ending Sep 30, 2020), the company now projects adjusted EPS to be around $7.25 compared with previous guidance of $6.65-$6.85. This is likely to be driven by company-wide sales growth of more than 30%.

Per Scotts Miracle-Gro, the momentum in the U.S. Consumer and Hawthorne segments is exceeding the company’s expectations. Its key business drivers over the past six months have been highly engaged retailer support and strong consumer demand. The company expects the trend to continue into the first quarter of fiscal 2021. Further, it expects lower expenses to act as tailwind next year.

Shares of Scotts Miracle-Gro have rallied 58% in the past year against the industry’s 12.6% decline.

Cramer is saying sell Scott's Miracle-Gro because people don't use fertilizer in the winter months.. Its almost like he has no idea whats really driving this stock.. The Hawthorne division.. Sure its great that the fertilizer and grass aspect of the business is profitable and providing shareholders with a nice dividend but its the Hawthorne division growing over 60% that's doubled this stock this year.

News: $SMG Scotts Miracle-Gro (SMG) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. Scotts Miracle-Gro   (NYSE: SMG) Q3 2020 Earnings Call Jul 29, 2020 , 9:00 a.m. ET Operator Continue reading

Find out more SMG - Scotts Miracle-Gro (SMG) Q3 2020 Earnings Call Transcript

Heck of a quarter, $5 special dividend and raised the quarterly dividend too. Way to go SMG!

News: $SMG Better Buy: Altria vs. Scotts Miracle-Gro

Cannabis investors have suffered some serious losses this year, and there's little hope of that changing anytime soon. That's why investing in stocks in other industries that also have exposure to the upside of the cannabis sector is the best option for marijuana investors today. Two stocks that...

Read the whole news SMG - Better Buy: Altria vs. Scotts Miracle-Gro

Scotts Miracle-Gro Company (NYSE: SMG) earns its spot as a marijuana stock thanks to the company's Hawthorne Gardening subsidiary, which ranks as the top supplier of hydroponic gardening products to the U.S. cannabis industry.

In Scotts' fiscal 2019 first quarter, this business contributed 47% of the company's total revenue.

SMG notes that each state’s cannabis industry and regulatory system are still in the process of maturing and says that “our experience growing an expansive, thriving business enterprise, and the company’s history of collaborating with government entities and other stakeholders to address difficult regulatory issues can provide invaluable insight and expertise to officials grappling with the challenges inherent in building comprehensive regulation for the cannabis industry. We are committed to working with regulatory bodies at all levels of government to help achieve these goals.”

Dividend Yield = 2.18%

May be a winner ?

Earnings Per Share (EPS) = 1.14

Market Cap = $ 5.45B

SMG CHART

News: $SMG ScottsMiracle-Gro Announces Third Quarter Results and Raises Guidance; U.S. Consumer and Hawthorne Segments Continue to Show Strong Growth

Roundup Agency Agreement amended, includes new economics and sale of brand extensions U.S. Consumer segment sales increase 10% in Q3, up 9% year-to-date Point-of-sale data shows consumer purchases up 4 percent entering August Hawthorne sales increase 138% in Q3 driven by ac...

In case you are interested ScottsMiracle-Gro Announces Third Quarter Results and Raises Guidance; U.S. Consumer and Hawthorne Segments Continue to Show Strong Growth

Scotts Miracle-Gro Increases Full-Year 2019 Revenue and Adjusted Earnings Per Share Guidance

View here